- Home
- FERG vs TAK Comparison
FERG vs TAK Comparison
Compare FERG & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FERG | TAK |
|---|---|---|
| Founded | 1887 | 1781 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Miscellaneous | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.8B | 43.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FERG | TAK |
|---|---|---|
| Price | $228.01 | $14.93 |
| Analyst Decision | Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $250.07 | N/A |
| AVG Volume (30 Days) | 1.6M | ★ 2.6M |
| Earning Date | 12-09-2025 | 01-29-2026 |
| Dividend Yield | 1.57% | ★ 3.56% |
| EPS Growth | ★ 18.63 | N/A |
| EPS | ★ 9.88 | 0.14 |
| Revenue | ★ $31,159,000,000.00 | $29,846,840,032.00 |
| Revenue This Year | $7.38 | N/A |
| Revenue Next Year | $5.90 | $0.59 |
| P/E Ratio | ★ $22.89 | $106.44 |
| Revenue Growth | ★ 4.92 | N/A |
| 52 Week Low | $146.00 | $12.80 |
| 52 Week High | $256.93 | $15.69 |
Technical Indicators
Market Signals| Indicator | FERG | TAK |
|---|---|---|
| Relative Strength Index (RSI) | 39.99 | 68.15 |
| Support Level | $221.50 | $14.43 |
| Resistance Level | $232.11 | $14.66 |
| Average True Range (ATR) | 5.47 | 0.16 |
| MACD | -1.65 | 0.05 |
| Stochastic Oscillator | 20.94 | 92.35 |
Price Performance
Historical ComparisonAbout FERG Ferguson plc
Ferguson distributes plumbing and HVAC products to North American repair, maintenance and improvement, new construction, and civil infrastructure markets. It serves over 1 million customers and sources products from 36,000 suppliers. Ferguson engages customers through approximately 1,800 North American branches, over the phone, online, and in residential showrooms. According to Modern Distribution Management, Ferguson is the largest plumbing distributor and second-largest HVAC distributor (next to Watsco) in North America. The firm sold its UK business in 2021 and is now solely focused on the North American market.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.